# Starling Oncology, Inc.: Form 8-K, filed Nov 12, 2024

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: 8-K
- Filed: 2024-11-12
- Accepted by EDGAR: Nov 12, 2024, 06:04 ET
- Period: 2024-11-08
- Accession: 0001079973-24-001491
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/toi_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/toi_8k.htm

Filed Nov 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001079973-24-001491. Last ingested by Listed: Nov 5, 2026, 19:51 ET. No prices; not investment advice.